Logo

Valiant Laboratories Ltd. Share Price

Pharmaceuticals & Drugs

Valiant Laboratories Ltd. (INR)104.610.1   (0.1%)

Exchange ScripsBSE543998NSEVALIANTLABISININE0JWS01017

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Valiant Laboratories Ltd. Performance

Market performance

Open price106.25
High107.9
Volumes40189
Prev Close104.61
Low104.12
Closing date2025-05-20

Historical performance

1 Year High157.49
3 Year High214.95
5 Year High214.95
1 Year Low75.20
3 Year Low75.20
5 Year Low75.20

Valiant Laboratories Ltd. Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
453
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
1421.33
Dividend Yield
Dividend Yield
N/A

Valiant Laboratories Ltd. Investment Returns

1 Year
-28.6%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Valiant Laboratories Ltd. Technicals

IndicatorsValueSignal
5-DMA103.46Bullish
10-DMA101.2Bullish
20-DMA101.26Bullish
50-DMA92.29Bullish
100-DMA97.81Bullish
200-DMA107.62Bearish

Shareholding Pattern

FieldMar-2025Dec-2024Sep-2024Jun-2024Mar-2024
Promoters88888
Foreign Investors---------------
Domestic Investors88888
Public Investors1502815684151811424114906
Government---------------

Valiant Laboratories Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Other Income9749
Operating Profit13400
Interest13
Depreciation2016
Profit Before Tax-8381
Consolidated Net Profit3290
Adjusted EPS---9

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Share Capital434326
Total Reserves1934679
Minority Interest------
Total Non-Current Liabilities767617
Total Liabilities34272130
Capital Work in Progress4267
Total Assets34272130

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023
Cash Flow from Operating Activities19561
Cash Flow from Investing Activities-1439-552
Cash Flow from Financing Activitie1524-9
Net Cash Inflow / Outflow105-1
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 1421.33.
  • 3Y Stock Price CAGR of the stock is -38.6.
  • The stock has a beta of 1.1.
  • In the last financial year, the company had an EBITDA of ₹13 Million.
  • The company generated revenue of ₹1821 Million in the previous financial year.

Valiant Laboratories Ltd.

104.610.1   (0.1%)

Investment Amount: ₹ 1000000
Current Value: ₹ 726963.2
No. of Shares: 6949.3
Performance:-27.3%
P/L: ₹-273036.8

Top Gainers

SymbolChange%
TATVA906.3(20%)
ALKALI108.24(20%)
HLEGLAS362.6(20%)
KAPSTON255.72(20%)
HTMEDIA21.56(20%)

Top Losers

SymbolChange%
GANESHBE108.81(-15%)
QUESS338.35(-9%)
JAYNECOIND39.95(-9%)
DOMS2548.8(-9%)
COCHINSHIP1817.6(-8%)
PROTEAN1048.4(-8%)
BAIDFIN10.47(-8%)
BAJAJHLDNG12932(-8%)

Similar stocks

Suven Life Sciences Ltd.

62.8

205.64

April 20 - May 20

Kilitch Drugs (India) Ltd.

34.4

471.3

April 20 - May 20

Aarti Drugs Ltd.

31.2

468.95

April 20 - May 20

NGL Fine-Chem Ltd.

26.1

1311.8

April 20 - May 20

Anuh Pharma Ltd.

21.9

208.79

April 20 - May 20

SMS Pharmaceuticals Ltd.

21

262.55

April 20 - May 20

Morepen Laboratories Ltd.

20

62.83

April 20 - May 20

Themis Medicare Ltd.

19.2

160.12

April 20 - May 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month